ATE441419T1 - Verwendung von loteprednoletabonat zur behanldung von trockenen augen - Google Patents

Verwendung von loteprednoletabonat zur behanldung von trockenen augen

Info

Publication number
ATE441419T1
ATE441419T1 AT05729286T AT05729286T ATE441419T1 AT E441419 T1 ATE441419 T1 AT E441419T1 AT 05729286 T AT05729286 T AT 05729286T AT 05729286 T AT05729286 T AT 05729286T AT E441419 T1 ATE441419 T1 AT E441419T1
Authority
AT
Austria
Prior art keywords
tabonate
loteprednole
dry eyes
treat dry
patient
Prior art date
Application number
AT05729286T
Other languages
English (en)
Inventor
Stephen Bartels
Original Assignee
Bausch & Lomb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34963566&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE441419(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bausch & Lomb filed Critical Bausch & Lomb
Application granted granted Critical
Publication of ATE441419T1 publication Critical patent/ATE441419T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
AT05729286T 2004-03-25 2005-03-24 Verwendung von loteprednoletabonat zur behanldung von trockenen augen ATE441419T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55616104P 2004-03-25 2004-03-25
PCT/US2005/009761 WO2005094836A2 (en) 2004-03-25 2005-03-24 Use of loteprednol etabonate for the treatment of dry eye

Publications (1)

Publication Number Publication Date
ATE441419T1 true ATE441419T1 (de) 2009-09-15

Family

ID=34963566

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05729286T ATE441419T1 (de) 2004-03-25 2005-03-24 Verwendung von loteprednoletabonat zur behanldung von trockenen augen

Country Status (15)

Country Link
US (1) US20050222110A1 (de)
EP (2) EP2127655A1 (de)
JP (1) JP2007530573A (de)
KR (1) KR20070004750A (de)
CN (1) CN1964719B (de)
AT (1) ATE441419T1 (de)
AU (1) AU2005229006B9 (de)
BR (1) BRPI0509220A (de)
CA (1) CA2560824A1 (de)
DE (1) DE602005016392D1 (de)
ES (1) ES2330762T3 (de)
HK (1) HK1102551A1 (de)
MX (1) MXPA06010849A (de)
TW (1) TW200602030A (de)
WO (1) WO2005094836A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7691811B2 (en) * 2006-05-25 2010-04-06 Bodor Nicholas S Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye
CN101317847B (zh) * 2007-06-06 2010-10-13 深圳市瑞谷医药技术有限公司 一种眼用或耳鼻用药物组合物及其用途
US20090239836A1 (en) * 2008-03-24 2009-09-24 Mary Lee Ciolkowski Multifunctional Ophthalmic Compositions
US8835410B2 (en) 2011-05-10 2014-09-16 Bodor Laboratories, Inc. Treatment of eyelid dermatitis
WO2013133980A1 (en) * 2012-03-05 2013-09-12 Bausch & Lomb Incorporated Nitroxy derivatives of soft steroids
KR102310775B1 (ko) 2012-05-03 2021-10-07 칼라 파마슈티컬스, 인크. 개선된 점막 수송을 나타내는 제약 나노입자
US9827191B2 (en) 2012-05-03 2017-11-28 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
AU2013256064B2 (en) 2012-05-03 2018-01-04 Alcon Inc. Pharmaceutical nanoparticles showing improved mucosal transport
US11596599B2 (en) 2012-05-03 2023-03-07 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
WO2014127214A1 (en) 2013-02-15 2014-08-21 Kala Pharmaceuticals, Inc. Therapeutic compounds and uses thereof
ES2831625T3 (es) 2013-02-20 2021-06-09 Kala Pharmaceuticals Inc Compuestos terapéuticos y sus usos
US9688688B2 (en) 2013-02-20 2017-06-27 Kala Pharmaceuticals, Inc. Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof
WO2015066482A1 (en) 2013-11-01 2015-05-07 Kala Pharmaceuticals, Inc. Crystalline forms of therapeutic compounds and uses thereof
US9890173B2 (en) 2013-11-01 2018-02-13 Kala Pharmaceuticals, Inc. Crystalline forms of therapeutic compounds and uses thereof
CN106279325A (zh) * 2015-05-27 2017-01-04 天津金耀集团有限公司 一种依碳氯替泼诺新晶型及其制备方法
CN106279324A (zh) * 2015-05-27 2017-01-04 天津金耀集团有限公司 依碳氯替泼诺一水合物及其晶型与制备方法
CN106892952A (zh) * 2015-12-21 2017-06-27 天津金耀集团有限公司 一种依碳氯替泼诺新晶型及其制备方法
CN106892953A (zh) * 2015-12-21 2017-06-27 天津金耀集团有限公司 依碳氯替泼诺一水合物及其晶型与制备方法
AU2017324716B2 (en) 2016-09-08 2020-08-13 KALA BIO, Inc. Crystalline forms of therapeutic compounds and uses thereof
AU2017324251A1 (en) 2016-09-08 2019-03-21 Kala Pharmaceuticals, Inc. Crystalline forms of therapeutic compounds and uses thereof
AU2017324713B2 (en) 2016-09-08 2020-08-13 KALA BIO, Inc. Crystalline forms of therapeutic compounds and uses thereof
EP3624773A4 (de) * 2017-05-19 2021-04-07 Ocugen, Inc. Ophthalmische zusammensetzungen und verfahren zur verwendung

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075A (en) 1847-04-17 Improvement in cultivators
US104A (en) 1836-12-10 Revolving hokse-rake
US4710495A (en) 1980-07-10 1987-12-01 Otsuka Pharmaceutical Co., Ltd. Soft steroids having anti-inflammatory activity
US4996335A (en) 1980-07-10 1991-02-26 Nicholas S. Bodor Soft steroids having anti-inflammatory activity
US6610675B1 (en) 1980-07-10 2003-08-26 Nicholas S. Bodor Inactive metabolite approach to soft drug design
US4883658A (en) 1986-04-28 1989-11-28 Holly Frank J Ophthalmic solution for treatment of dry-eye syndrome
US4804539A (en) 1986-07-28 1989-02-14 Liposome Technology, Inc. Ophthalmic liposomes
US5278151A (en) 1987-04-02 1994-01-11 Ocular Research Of Boston, Inc. Dry eye treatment solution
US4914088A (en) 1987-04-02 1990-04-03 Thomas Glonek Dry eye treatment solution and method
ES2084722T3 (es) 1990-05-29 1996-05-16 Boston Ocular Res Composicion para tratamiento del ojo seco.
ZA912797B (en) 1990-05-29 1992-12-30 Boston Ocular Res Dry eye treatment process and solution
ZA927277B (en) 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
US5540930A (en) * 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
WO1997020578A1 (en) 1995-12-04 1997-06-12 University Of Miami Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance
US6096052A (en) * 1998-07-08 2000-08-01 Ovion, Inc. Occluding device and method of use
US7073504B2 (en) * 1996-12-18 2006-07-11 Ams Research Corporation Contraceptive system and method of use
TW503113B (en) 1997-01-16 2002-09-21 Senju Pharma Co Aqueous suspension for nasal administration
KR100508227B1 (ko) 1997-03-14 2006-03-23 센주 세이야꾸 가부시키가이샤 로테프레드놀에타보네이트수성현탁액
DE19947234A1 (de) * 1999-09-30 2001-04-05 Asta Medica Ag Neue Kombination von Loteprednol und Antihistaminika
CA2447918A1 (en) 2001-05-21 2002-11-28 Alcon, Inc. Method of treating dry eye disorders
CA2462272A1 (en) * 2001-10-11 2003-04-17 Alcon, Inc. Methods for treating dry eye by a combination of an antiinflammatory steroid and a muc-1 secretagogue
CA2477044A1 (en) * 2002-02-22 2003-09-04 Pharmacia Corporation Ophthalmic formulation with gum system
US7074426B2 (en) * 2002-03-27 2006-07-11 Frank Kochinke Methods and drug delivery systems for the treatment of orofacial diseases
WO2004058272A1 (en) * 2002-12-20 2004-07-15 Control Delivery Systems, Inc. Steroid compositions for intraocular use
WO2004073748A1 (ja) * 2003-02-20 2004-09-02 Senju Pharmaceutical Co., Ltd. 水性懸濁液剤
US20050182039A1 (en) * 2004-02-13 2005-08-18 Bausch & Lomb Incorporated Use of Loteprednol etabonate for the treatment of dry eye

Also Published As

Publication number Publication date
BRPI0509220A (pt) 2007-09-04
US20050222110A1 (en) 2005-10-06
CN1964719B (zh) 2010-05-05
AU2005229006A1 (en) 2005-10-13
CA2560824A1 (en) 2005-10-13
KR20070004750A (ko) 2007-01-09
DE602005016392D1 (de) 2009-10-15
WO2005094836A3 (en) 2006-01-26
AU2005229006B2 (en) 2011-01-20
EP1744759A2 (de) 2007-01-24
TW200602030A (en) 2006-01-16
HK1102551A1 (en) 2007-11-30
ES2330762T3 (es) 2009-12-15
CN1964719A (zh) 2007-05-16
JP2007530573A (ja) 2007-11-01
MXPA06010849A (es) 2007-03-08
EP1744759B1 (de) 2009-09-02
EP2127655A1 (de) 2009-12-02
WO2005094836A2 (en) 2005-10-13
AU2005229006B9 (en) 2011-05-19

Similar Documents

Publication Publication Date Title
ATE441419T1 (de) Verwendung von loteprednoletabonat zur behanldung von trockenen augen
WO2005096981A3 (en) Method and apparatus for dermatological treatment
EA200801717A1 (ru) Композиция местного применения по уходу за кожей, продукт на ее основе и способ лечения
DE60312309D1 (de) Verwendung von botulinum toxin zur behandlung von herz- und kreislaufskrankheiten
ATE551996T1 (de) Behandlung oder prävention von diabetes mit cannabidiol
EA200501897A2 (ru) Ручное устройство и способ светолечения
ATE509663T1 (de) Ballon-brachytherapie-applikator
DE60333605D1 (de) Tuberkulosebehandlung mit Pleuromutilinderivaten
ATE368455T1 (de) Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
ATE448779T1 (de) Methode zur behandlung trockener augen und uveitis
ATE289816T1 (de) Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen
CN108785843A (zh) 一种美容方法
WO2003057162A3 (en) Combination for the treatment of immunoinflammatory disorders and proliferative skin diseases
ATE380554T1 (de) Verwendung von xenon mit hypothermie zur behandlung von neugeborenen-asphyxie
ATE447426T1 (de) Elektromagnetische stimulation bei patienten mit osteoporose
WO2004045554A3 (en) Cytomodulating peptides for treating interstitial cystitis
ATE487480T1 (de) Perhexilin zur behandlung von chronischer herzinsuffizienz
DE60216292D1 (de) Calciumtrifluoracetat mit zytotoxischer wirkung
ATE367823T1 (de) E-selectin zur behandlung oder vorbeugung von schlaganfall
EP1495755B8 (de) Verwendung von Citrullin zur Herstellung eines Arzneimittels zur Behandlung von ans Altern oder an eine Bestrahlung gebundener intestinaler Insuffizienz
DE60020111D1 (de) Therapeutische anwendung von cannabinoiden zur hirntumorbehandlung
CN203710557U (zh) 脑血管病人康复用头部按摩器
CN209679297U (zh) 一种石英表式激光电子脉冲治疗仪
ATE359088T1 (de) Verwendung von interleukin-18 zur behandlung von uv-assoziierten hautkrankheiten
TW200509922A (en) Methods of therapeutic treatment using amounts of retinoid components

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties